Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Docklands, Victoria-based Bionic Vision Technologies operates in Biotechnology Research. It is privately held, and its site is bionicvis.com. It holds two addresses on record, all in Australia. Headcount on record is 2. One Australian registration (ABN) is a confirmed match. Its latest round on record is Series A, US$18.0M. It is listed alongside six similar brands, mostly in Robotics Engineering.
ABN96124162634
| BIONIC VISION TECHNOLOGIES PTY LTD | ABN 96124162634 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Bionic Vision Technologies (BVT) is a privately held Australian company that develops visual prostheses to restore vision to the blind. The devices operate by electrically stimulating the remaining retinal cells in patients with retinal degeneration.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
| Rounds | 2 |
|---|---|
| Axis | 2010 to 2026 |
| Series A · 3 May 2017 | US$ 18.0M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
One Victoria entity on the ABR: BIONIC VISION TECHNOLOGIES PTY LTD (ABN 96 124 162 634), high confidence.
2 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Two addresses on record, Australia only. Primary: 727 Collins St, Level 23, Collins Square Tower Five, Docklands, Victoria 3008.
Two rounds. Latest 3 May 2017: Series A, US$18,000,000, investors State Path Capital Limited and China Huarong International Holdings.
3 profiles list Bionic Vision Technologies as a peer — 49th percentile in Biotechnology Research. It lists ten peers of its own. Cyclopharm and Bionic Vision Australia list it back.